TRIMAS CORPORATION

TRS

CIK 0000842633 · Quarterly mode · latest period FY2026 (Q1) (ending 2026-03-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q1)

Revenue
$168M
↑+10.4% +$16Mvs FY2025 (Q1)
Operating Income
$7M
↓-3.6% -$260Kvs FY2025 (Q1)
Gross Profit
$37M
↑+12.3% +$4Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
56/100
  • Profitability
    0ROIC 3.7% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.52 (above 1.5 = solid)
  • Leverage
    66D/E 0.67 (under 0.5 = conservative)
  • Efficiency
    20Asset Turnover 0.46x (1.0+ = capital-efficient)
  • Growth
    51Revenue YoY +10.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 4.1% · trend +3.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project TRS's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 37.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$56.50
Total enterprise IV
$2.30B
Diluted shares
0.04B
Terminal PV
$1.79B (78% of total)
Year-5 FCF
$211M
YearProjected FCFDiscounted PV
+1$86M$79M
+2$108M$89M
+3$135M$101M
+4$169M$115M
+5$211M$131M
Terminal$2.88B$1.79B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$41M
investment in PP&E
Dividends paid (TTM)
$6M
cash returned to holders
Stock buybacks (TTM)
$157M
share count reduction
Stock-based comp (TTM)
$12M
non-cash dilution

Balance sheet · 2026-03-31

latest filed snapshot
Total assets
$2.30B
everything owned
Total liabilities
$847M
everything owed
Stockholders' equity
$1.45B
shareholder claim
Net debt
$-837M
Net cash position ($837M)

Recent performance · 64 quarters

Revenue↑+10.4% +$16M
$168M
Net Income↑+6347.9% +$788M
$801M
Free Cash Flow↓-556.0% -$21M
$-25M
Operating Margin↓-0.6pts
4.1%

Drill down